Nancy Smith-Hall

Statistics

Publications

Citations

487

H-Index

Active since

2005

Affiliations

Mayo Clinic(Current)

Procter & Gamble (United States)

WinnMed

Nancy Smith-Hall is an author at Mayo Clinic specializing in gastrointestinal pharmacotherapy, oral drug delivery, and inflammatory bowel disease therapy.

Publications per year

2005–2007

Publications

Delayed-Release Oral Mesalamine at 4.8 g/day (800 mg tablet) for the Treatment of Moderately Active Ulcerative Colitis: The ASCEND II Trial

Stephen B. Hanauer, William J. Sandborn, Asher Kornbluth et al. · The American Journal of Gastroenterology · 2005 · 323 citations

Medicine, Pharmacology, Pharmacotherapy +9

Delayed-Release Oral Mesalamine 4.8 g/day (800 mg tablets) Compared with 2.4 g/day (400 mg tablets) for the Treatment of Mildly to Moderately Active Ulcerative Colitis: The ASCEND I Trial

Stephen B. Hanauer, William J. Sandborn, Christian Dallaire et al. · Canadian Journal of Gastroenterology · 2007 · 164 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +14

1–2 of 2